Linden Care, a provider of specialty pharmacy services to the pain management industry, has appointed Michael W. Grieco as CFO. Linden Care is backed by BelHealth Investment Partners.
Linden Care LLC (“Linden Care” or the “Company”), a leading provider of specialty pharmacy services to the pain management industry, today announced the addition of Michael W. Grieco as CFO. Mr. Grieco brings a wealth of experience to the position and further solidifies a deeply experienced management team.
Mr. Grieco has over 30 years of experience in progressive financial and accounting roles. Most recently, he served as Vice President, Finance and Mergers & Acquisitions (“M&A”) of Gentiva Health Services, Inc. (NASDAQ:GTIV), the largest provider of home health and hospice care in the United States. While at Gentiva, Mr. Grieco led their acquisition efforts and was instrumental in driving Company revenue in excess of $1.5 billion. In addition to his M&A expertise, Mr. Grieco will provide leadership and discipline to the finance and accounting operations.
About Linden Care
Linden Care, headquartered in Syosset, NY, is a leading provider of specialty pharmacy services to the pain management industry. The Company offers comprehensive and highly personalized specialty pharmacy services targeting multiple growth markets through a unique “concierge pharmacy” business model. Since inception, the Company has distinguished itself by providing robust and differentiated compliance practices as well as a full suite of “specialty” services to meet the needs of patients, physicians and pharmaceutical manufacturers. The Company will continue to expand this successful strategy, currently focused on the Northeast, throughout the rest of the country, becoming the national center of excellence for pain management.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies we believe would benefit from our vast operating and private equity experience. The firm typically invests $10-25 million per platform company across three healthcare segments: Services, Information Technology and Products & Distribution. Applying an active, hands-on approach, BelHealth utilizes its experience to support management to drive revenue, profit growth and achieve superior returns for our investors and partners.
For further information, please visit:
Linden Care: www.lindencare.com BelHealth Investment Partners: www.belhealth.com
Linden Care: Marc Wiener and Mark Bortnick (516) 221-7600 BelHealth Investment Partners: Inder Tallur (347) 308-7018